Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	muscle cell development	CACNA1S FLNC MYH10 HDAC4 NKX2-6 NIBAN2 BIN3 DICER1 TMTC3 PRKAR1A KDM1A MYBPC1	4.80e-06	259	188	12	GO:0055001
HumanPheno	Abnormality of hand joint mobility	COL6A3 FLNC COL12A1 HDAC4 CHSY1 NFASC BRAF	1.05e-05	57	70	7	HP:0006256
HumanPheno	Aplasia/hypoplasia involving the skeleton	TCTN3 COL6A3 FLNC COL12A1 GALNT2 HDAC4 NRCAM RASA2 CHSY1 PEX10 SHOX NFASC NKX2-6 CHD7 TRRAP TERT DICER1 PGM1 LIMK1 ARSL BRAF PURA ABCD4 USP7 PRKAR1A UHRF1 TRPV4 PAX1 COASY HEPHL1 KDM1A PUS7 ADAMTSL2 MYBPC1 FOXC2	1.79e-05	1343	70	35	HP:0009115
HumanPheno	Aplasia/Hypoplasia involving bones of the skull	TCTN3 COL6A3 COL12A1 NRCAM RASA2 CHSY1 PEX10 SHOX NFASC CHD7 TRRAP TERT DICER1 PGM1 LIMK1 ARSL BRAF PURA ABCD4 PRKAR1A UHRF1 PAX1 COASY PUS7 ADAMTSL2 MYBPC1 FOXC2	3.49e-05	915	70	27	HP:0009116
HumanPheno	Small joint hypermobilty	COL6A3 COL12A1 HDAC4 CHSY1 NFASC BRAF TRPV4	3.74e-05	69	70	7	HP:0430046
HumanPheno	Increased urinary cortisol level	TERT BRAF PRKAR1A KDM1A	5.26e-05	16	70	4	HP:0012030
HumanPheno	Paradoxical increased cortisol secretion on dexamethasone suppression test	TERT BRAF PRKAR1A KDM1A	5.26e-05	16	70	4	HP:0003466
HumanPheno	Finger joint hypermobility	COL6A3 COL12A1 HDAC4 CHSY1 NFASC BRAF	6.71e-05	52	70	6	HP:0006094
HumanPheno	Aplasia/hypoplasia affecting bones of the axial skeleton	TCTN3 COL6A3 COL12A1 NRCAM RASA2 CHSY1 PEX10 SHOX NFASC CHD7 TRRAP TERT DICER1 PGM1 LIMK1 ARSL BRAF PURA ABCD4 PRKAR1A UHRF1 TRPV4 PAX1 COASY PUS7 ADAMTSL2 MYBPC1 FOXC2	7.17e-05	1008	70	28	HP:0009122
HumanPheno	Abnormal urine hormone level	TERT BRAF PRKAR1A KDM1A	1.08e-04	19	70	4	HP:0012029
Domain	-	COL12A1 FAT3 CELSR3 PAPPA LMAN2 WDFY3 LRBA	4.74e-05	95	187	7	2.60.120.200
Domain	ConA-like_dom	COL12A1 FAT3 EGFL6 BTN2A2 CELSR3 PTPRK PAPPA LMAN2 WDFY3 LRBA	7.43e-05	219	187	10	IPR013320
Domain	FN3	COL6A3 FLNC COL12A1 NRCAM NFASC PTPRG PTPRK TNXB MYBPC1	1.06e-04	185	187	9	SM00060
Domain	-	ACADS GCDH ACOX2	2.62e-04	13	187	3	1.10.540.10
Domain	AcylCoA_DH/ox_N	ACADS GCDH ACOX2	2.62e-04	13	187	3	IPR013786
Domain	FN3_dom	COL6A3 FLNC COL12A1 NRCAM NFASC PTPRG PTPRK TNXB MYBPC1	2.64e-04	209	187	9	IPR003961
Domain	CNMP_BINDING_1	HCN1 PNPLA6 PRKAR1A CNGA3	2.81e-04	32	187	4	PS00888
Domain	CNMP_BINDING_2	HCN1 PNPLA6 PRKAR1A CNGA3	2.81e-04	32	187	4	PS00889
Domain	cNMP	HCN1 PNPLA6 PRKAR1A CNGA3	3.57e-04	34	187	4	SM00100
Domain	cNMP_binding	HCN1 PNPLA6 PRKAR1A CNGA3	3.57e-04	34	187	4	PF00027
Domain	cNMP-bd_dom	HCN1 PNPLA6 PRKAR1A CNGA3	4.00e-04	35	187	4	IPR000595
Domain	CNMP_BINDING_3	HCN1 PNPLA6 PRKAR1A CNGA3	4.00e-04	35	187	4	PS50042
Domain	Acyl-CoA_Oxase/DH_cen-dom	ACADS GCDH ACOX2	4.11e-04	15	187	3	IPR006091
Domain	AcylCoA_DH/oxidase_NM_dom	ACADS GCDH ACOX2	4.11e-04	15	187	3	IPR009100
Domain	Acyl-CoA_dh_M	ACADS GCDH ACOX2	4.11e-04	15	187	3	PF02770
Domain	cNMP-bd_CS	HCN1 PRKAR1A CNGA3	5.02e-04	16	187	3	IPR018488
Domain	AcylCo_DH/oxidase_C	ACADS GCDH ACOX2	5.02e-04	16	187	3	IPR009075
Domain	cNMP-bd-like	HCN1 PNPLA6 PRKAR1A CNGA3	5.50e-04	38	187	4	IPR018490
Domain	Neurofascin/L1/NrCAM_C	NRCAM NFASC	5.90e-04	4	187	2	IPR026966
Domain	Bravo_FIGEY	NRCAM NFASC	5.90e-04	4	187	2	PF13882
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RALGDS CHSY1 NFASC CACHD1 DICER1 AFAP1 CELSR3 ATP11B SUPT6H KLHL21 ANAPC2 CCSER2 RACGAP1 RAB11FIP5 FTO KDM1A	4.48e-08	529	191	16	14621295
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MYH10 HDAC4 NRCAM GIT1 HCN1 SENP3 NFASC CHD7 EDC4 BTBD9 CCDC6 GRM5 HDAC3 SSH1 PURA TAGLN3 PRKAR1A RACGAP1 WDFY3 KDM1A	4.10e-07	963	191	20	28671696
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	FRMPD1 CHSY1 DNAH7 DICER1 BTBD3 ATP11B WDFY3	1.60e-06	102	191	7	10231032
Pubmed	Mouse model resources for vision research.	HCN1 MDM1 HPS1 PAX1 CNGA3	3.03e-06	41	191	5	21052544
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	TCTN3 SUMF2 COL12A1 MAN1A1 GALNT2 CHSY1 CACHD1 PTGS1 JAG2 SLC6A6 EEF1D GLA CELSR3 TMTC3 PTPRK SEMA3B UHRF1 SLC39A6 LMAN2 TAGLN2 CTSD	3.21e-06	1201	191	21	35696571
Pubmed	Catalog of 605 single-nucleotide polymorphisms (SNPs) among 13 genes encoding human ATP-binding cassette transporters: ABCA4, ABCA7, ABCA8, ABCD1, ABCD3, ABCD4, ABCE1, ABCF1, ABCG1, ABCG2, ABCG4, ABCG5, and ABCG8.	ABCA4 ABCA8 ABCD4	3.22e-06	6	191	3	12111378
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	STARD8 CMTR1 BTBD9 ABCA8 ASAP2 MYO15B SSH1 TULP4 TAGLN2 CSTF2T PUS7 MAST3 ADAMTSL2	3.86e-06	493	191	13	15368895
Pubmed	A "double adaptor" method for improved shotgun library construction.	HDAC4 MDM1 NFASC MCM7 GRM5 DICER1 SUPT6H TMEM268 CCSER2 AOC3 PRKAR1A TAGLN2 WDFY3 FTO	3.99e-06	574	191	14	8619474
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	HDAC4 NRCAM CACHD1 BTBD3 ASAP2 CELSR3 MAST3	8.07e-06	130	191	7	12421765
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SPTLC3 SLC25A42 MYH10 GALNT2 HDAC4 RASA2 FRMPD1 NFASC BTBD9 TRRAP AR JAG2 ASAP2 PNPLA6 ATP11B PTPRG TULP4 SUPT6H PURA SEMA3B ASS1 LRBA TATDN1	8.18e-06	1489	191	23	28611215
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	MYH10 HDAC4 GIT1 NEK7 MCM7 CCDC6 BIN3 TRRAP HDAC3 EEF1D ASAP2 FAF2 BRAF PURA USP7 PRKAR1A RACGAP1 TAGLN2 LRBA BCAR3 GOT2	8.89e-06	1284	191	21	17353931
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	MYH10 SENP3 MCM7 CHD7 EDC4 TRRAP HMG20A PURA USP7 RACGAP1 UHRF1	1.28e-05	394	191	11	27248496
Pubmed	Ankyrin-based subcellular gradient of neurofascin, an immunoglobulin family protein, directs GABAergic innervation at purkinje axon initial segment.	GAD2 HCN1 NFASC	1.34e-05	9	191	3	15479642
Pubmed	Large-scale concatenation cDNA sequencing.	HDAC4 MDM1 NFASC MCM7 GRM5 DICER1 SUPT6H TMEM268 AOC3 PRKAR1A TAGLN2 WDFY3 FTO	1.74e-05	568	191	13	9110174
Pubmed	Characterization of the Cardiac Overexpression of HSPB2 Reveals Mitochondrial and Myogenic Roles Supported by a Cardiac HspB2 Interactome.	FLNC SLC25A42 PGM1 ABCD4 ACAA2 CTSD TATDN1	1.80e-05	147	191	7	26465331
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MPO FLNC MYH10 RASA2 SENP3 WDR46 NEK7 MCM7 CHD7 TRRAP EEF1D PNPLA6 FAF2 ASS1 USP7 RACGAP1 ACAA2 WDFY3 CTSD KDM1A GOT2	1.94e-05	1353	191	21	29467282
Pubmed	Control of developmentally primed erythroid genes by combinatorial co-repressor actions.	TRRAP HMG20A HDAC3 KDM1A	2.16e-05	30	191	4	26593974
Pubmed	Interaction of nuclear receptor zinc finger DNA binding domains with histone deacetylase.	HDAC4 AR HDAC3	2.60e-05	11	191	3	12943985
Pubmed	Lysine-specific demethylase 1 has dual functions as a major regulator of androgen receptor transcriptional activity.	AR KDM1A	3.00e-05	2	191	2	25482560
Pubmed	Inhibition of telomerase potentiates enzalutamide efficiency of androgen-sensitive human prostate cancer cells.	TERT AR	3.00e-05	2	191	2	29332354
Pubmed	LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.	AR KDM1A	3.00e-05	2	191	2	16079795
Pubmed	Molecular testing of BRAF, RAS and TERT on thyroid FNAs with indeterminate cytology improves diagnostic accuracy.	TERT BRAF	3.00e-05	2	191	2	29094776
Pubmed	BRAF V600E and TERT promoter mutations in paediatric and young adult papillary thyroid cancer and clinicopathological correlation.	TERT BRAF	3.00e-05	2	191	2	33027050
Pubmed	HCN1 Channels Enhance Rod System Responsivity in the Retina under Conditions of Light Exposure.	HCN1 CNGA3	3.00e-05	2	191	2	26807953
Pubmed	ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease.	ADAM30 CTSD	3.00e-05	2	191	2	27333034
Pubmed	Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.	TERT BRAF	3.00e-05	2	191	2	37771077
Pubmed	Histone Demethylase LSD1 Regulates Kidney Cancer Progression by Modulating Androgen Receptor Activity.	AR KDM1A	3.00e-05	2	191	2	32847068
Pubmed	TERT promoter mutation determines apoptotic and therapeutic responses of BRAF-mutant cancers to BRAF and MEK inhibitors: Achilles Heel.	TERT BRAF	3.00e-05	2	191	2	32561648
Pubmed	TERT and BRAF V600E mutations in thyroid cancer of World Trade Center Responders.	TERT BRAF	3.00e-05	2	191	2	37144982
Pubmed	Ultra-Deep DNA Methylation Analysis of X-Linked Genes: GLA and AR as Model Genes.	AR GLA	3.00e-05	2	191	2	32512878
Pubmed	BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.	TERT BRAF	3.00e-05	2	191	2	25024077
Pubmed	Histone deacetylase 3, a class I histone deacetylase, suppresses MAPK11-mediated activating transcription factor-2 activation and represses TNF gene expression.	HDAC3 MAPK11	3.00e-05	2	191	2	15356147
Pubmed	BRAF and TERT promoter mutations: clinical application in thyroid cancer.	TERT BRAF	3.00e-05	2	191	2	32321884
Pubmed	Association of BRAF or TERT Promoter Mutations and Advanced Papillary Thyroid Carcinoma.	TERT BRAF	3.00e-05	2	191	2	38925831
Pubmed	Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma.	NIBAN2 BRAF	3.00e-05	2	191	2	19362540
Pubmed	Molecular characterization and in situ localization of a mouse retinal taurine transporter.	SLC6A6 PRKAR1A	3.00e-05	2	191	2	9375654
Pubmed	BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients.	TERT BRAF	3.00e-05	2	191	2	27064992
Pubmed	[BRAF V600E Mutation and TERT Promoter Mutation in Papillary Thyroid Carcinomas and Their Association with Clinicopathological Characteristics].	TERT BRAF	3.00e-05	2	191	2	31880125
Pubmed	Diosgenin inhibits prostate cancer progression by inducing UHRF1 protein degradation.	USP7 UHRF1	3.00e-05	2	191	2	36681316
Pubmed	Risk-stratified Distant Metastatic Thyroid Cancer with Clinicopathological Factors and BRAF/TERT Promoter Mutations.	TERT BRAF	3.00e-05	2	191	2	37922948
Pubmed	Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis.	TERT BRAF	3.00e-05	2	191	2	29037127
Pubmed	Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness.	TERT BRAF	3.00e-05	2	191	2	26055532
Pubmed	Genetic trio of BRAF and TERT alterations and rs2853669TT in papillary thyroid cancer aggressiveness.	TERT BRAF	3.00e-05	2	191	2	38113409
Pubmed	Lymph Node Metastasis in Papillary Thyroid Carcinoma, A Study of BRAF V600E and TERT Promoter Mutations.	TERT BRAF	3.00e-05	2	191	2	38918666
Pubmed	EDC4 interacts with and regulates the dephospho-CoA kinase activity of CoA synthase.	EDC4 COASY	3.00e-05	2	191	2	22982864
Pubmed	Anti-tumor effect of apicidin on Ishikawa human endometrial cancer cells both in vitro and in vivo by blocking histone deacetylase 3 and 4.	HDAC4 HDAC3	3.00e-05	2	191	2	19956841
Pubmed	Wild-type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development.	TERT AR	3.00e-05	2	191	2	17991730
Pubmed	Conditional inactivation of Miwi2 reveals that MIWI2 is only essential for prospermatogonial development in mice.	PIWIL4 MOV10L1	3.00e-05	2	191	2	24464225
Pubmed	Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas.	TERT BRAF	3.00e-05	2	191	2	27911794
Pubmed	The complete sequence of the human locus for NgCAM-related cell adhesion molecule reveals a novel alternative exon in chick and man and conserved genomic organization for the L1 subfamily.	LAMB4 NRCAM	3.00e-05	2	191	2	11483367
Pubmed	The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin.	AR USP7	3.00e-05	2	191	2	26175158
Pubmed	Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT.	TERT BRAF	3.00e-05	2	191	2	25870252
Pubmed	Characterization of TERT and BRAF copy number variation in papillary thyroid carcinoma: An analysis of the cancer genome atlas study.	TERT BRAF	3.00e-05	2	191	2	33305870
Pubmed	De-SUMOylation of FOXC2 by SENP3 promotes the epithelial-mesenchymal transition in gastric cancer cells.	SENP3 FOXC2	3.00e-05	2	191	2	25216525
Pubmed	Facilitation of Definitive Cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With Thyroid Nodules.	TERT BRAF	3.00e-05	2	191	2	37505499
Pubmed	Neurofascin induces neurites by heterophilic interactions with axonal NrCAM while NrCAM requires F11 on the axonal surface to extend neurites.	NRCAM NFASC	3.00e-05	2	191	2	8922386
Pubmed	USP7 reduces the level of nuclear DICER, impairing DNA damage response and promoting cancer progression.	DICER1 USP7	3.00e-05	2	191	2	37867415
Pubmed	Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAF (V600E) Harboring Pediatric Papillary Thyroid Carcinomas.	TERT BRAF	3.00e-05	2	191	2	26951110
Pubmed	Frequent BRAF V600E and Absence of TERT Promoter Mutations Characterize Sporadic Pediatric Papillary Thyroid Carcinomas in Japan.	TERT BRAF	3.00e-05	2	191	2	28176151
Pubmed	TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.	TERT BRAF	3.00e-05	2	191	2	24617711
Pubmed	Uncommon TERT Promoter Mutations in Pediatric Thyroid Cancer.	TERT BRAF	3.00e-05	2	191	2	26711586
Pubmed	lncRNA TRMP-S directs dual mechanisms to regulate p27-mediated cellular senescence.	USP7 UHRF1	3.00e-05	2	191	2	34094715
Pubmed	Efficient Salmonella entry requires activity cycles of host ADF and cofilin.	LIMK1 SSH1	3.00e-05	2	191	2	15056216
Pubmed	Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTC.	TERT BRAF	3.00e-05	2	191	2	26461266
Pubmed	The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer.	TERT BRAF	3.00e-05	2	191	2	35501518
Pubmed	Blocking hyperactive androgen receptor signaling ameliorates cardiac and renal hypertrophy in Fabry mice.	AR GLA	3.00e-05	2	191	2	25701874
Pubmed	TERT accelerates BRAF mutant-induced thyroid cancer dedifferentiation and progression by regulating ribosome biogenesis.	TERT BRAF	3.00e-05	2	191	2	37647391
Pubmed	TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAFV600E/TERT promoter double-mutated glioma.	TERT BRAF	3.00e-05	2	191	2	31391125
Pubmed	Mechanisms of TERT Reactivation and Its Interaction with BRAFV600E.	TERT BRAF	3.00e-05	2	191	2	32981294
Pubmed	Identification of a novel human member of the DEAD box protein family.	DDX42 DICER1	3.00e-05	2	191	2	10727850
Pubmed	Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis.	TERT BRAF	3.00e-05	2	191	2	28666074
Pubmed	Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission Probability.	TERT BRAF	3.00e-05	2	191	2	30501571
Pubmed	TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy.	TERT BRAF	3.00e-05	2	191	2	34936949
Pubmed	The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA.	USP7 FTO	3.00e-05	2	191	2	30905413
Pubmed	Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer.	TERT BRAF	3.00e-05	2	191	2	25584719
Pubmed	Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer.	TERT BRAF	3.00e-05	2	191	2	31305897
Pubmed	BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients.	TERT BRAF	3.00e-05	2	191	2	26943032
Pubmed	Presence of TERT ± BRAF V600E mutation is not a risk factor for the clinical management of patients with papillary thyroid microcarcinoma.	TERT BRAF	3.00e-05	2	191	2	33952391
Pubmed	A six-genotype genetic prognostic model for papillary thyroid cancer.	TERT BRAF	3.00e-05	2	191	2	27875244
Pubmed	Lysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene.	TERT KDM1A	3.00e-05	2	191	2	18197256
Pubmed	Androgen receptor overexpression in prostate cancer linked to Pur alpha loss from a novel repressor complex.	AR PURA	3.00e-05	2	191	2	18413735
Pubmed	LSD1 and Aberrant DNA Methylation Mediate Persistence of Enteroendocrine Progenitors That Support BRAF-Mutant Colorectal Cancer.	BRAF KDM1A	3.00e-05	2	191	2	34035083
Pubmed	CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer.	CCDC6 USP7	3.00e-05	2	191	2	30786932
Pubmed	Telomere dysfunction in Tert knockout mice delays BrafV600E -induced melanoma development.	TERT BRAF	3.00e-05	2	191	2	37727982
Pubmed	Astrocytes regulate ultra-slow arteriole oscillations via stretch-mediated TRPV4-COX-1 feedback.	PTGS1 TRPV4	3.00e-05	2	191	2	34348138
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	SUMF2 SPNS1 MYH10 COL12A1 GALNT2 GCDH TRRAP EEF1D AFAP1 GLA TMTC3 TAGLN3 ASS1 PRKAR1A RACGAP1 LMAN2 TAGLN2 CTSD SEC23B GOT2	3.38e-05	1297	191	20	33545068
Pubmed	Ran binding protein 9 interacts with Raf kinase but does not contribute to downstream ERK1/2 activation in skeletal myoblasts.	PURA PRKAR1A MYBPC1	3.46e-05	12	191	3	16364241
Pubmed	Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases.	HDAC4 AR PAX1	4.48e-05	13	191	3	22693459
Pubmed	Conserved molecular signatures of neurogenesis in the hippocampal subgranular zone of rodents and primates.	GAD2 HCN1 NEK7 PTGS1 LIMK1 AFAP1 ATP11B RAB11FIP5 CTSD MYBPC1	4.81e-05	376	191	10	24154525
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	TCTN3 GALNT2 NIBAN2 TRRAP SNX13 PNPLA6 ATP11B TMTC3 BAIAP2L1 ANAPC2 ABCD4 RAB11FIP5 LRBA GOT2	4.83e-05	719	191	14	35337019
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	FLNC GALNT2 DDX42 WDR46 MCM7 EDC4 TRRAP DICER1 EEF1D SUPT6H PRKAR1A RACGAP1 UHRF1 LMAN2 TAGLN2 KDM1A GOT2	5.52e-05	1024	191	17	24711643
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	SUPT3H ABCA4 STARD8 SPOPL METRNL DUSP5 DDX42 CHD7 EDC4 CCDC6 TRRAP SNAP47 HDAC3 ART4 COG6 KLHL21 EXOC3L2 FTO LRRC23	5.96e-05	1242	191	19	30973865
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	SUMF2 MAN1A1 GALNT2 CHSY1 GCDH CACHD1 EDC4 JAG2 PNPLA6 GLA FAF2 TMTC3 BAIAP2L1 PTPRK ANAPC2 LMAN2	7.06e-05	942	191	16	31073040
Pubmed	Quantitative trait loci for steady-state platelet count in mice.	ABCA8 OR1E1 OR1E3	7.07e-05	15	191	3	15520881
Pubmed	Androgen receptor corepressor-19 kDa (ARR19), a leucine-rich protein that represses the transcriptional activity of androgen receptor through recruitment of histone deacetylase.	HDAC4 AR	8.97e-05	3	191	2	14576337
Pubmed	Breeding scheme and maternal small RNAs affect the efficiency of transgenerational inheritance of a paramutation in mice.	DICER1 MOV10L1	8.97e-05	3	191	2	25783852
Pubmed	Histone deacetylases and the nuclear receptor corepressor regulate lytic-latent switch gene 50 in murine gammaherpesvirus 68-infected macrophages.	HDAC4 HDAC3	8.97e-05	3	191	2	20719946
Pubmed	TIP60 governs the auto‑ubiquitination of UHRF1 through USP7 dissociation from the UHRF1/USP7 complex.	USP7 UHRF1	8.97e-05	3	191	2	34558642
Pubmed	Clinical Utility of BRAF, NRAS, and TERT Promoter Mutation in Preoperative Thyroid Fine-Needle Aspiration Biopsy: A Diagnostic Study From Dharmais Cancer Hospital.	TERT BRAF	8.97e-05	3	191	2	33247684
Pubmed	Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation.	HDAC4 AR	8.97e-05	3	191	2	21242980
GeneFamily	Sulfotransferases, membrane bound	HS6ST1 CHST4 CHST7 HS3ST2	1.67e-04	37	136	4	763
GeneFamily	Fibronectin type III domain containing	COL12A1 NRCAM NFASC PTPRG PTPRK TNXB MYBPC1	2.09e-04	160	136	7	555
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	COL6A3 MYH10 FAT3 NFASC ABCA8 PTPRG TMEM108 HS3ST2 TNXB ADAMTSL2	8.41e-09	187	190	10	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC FRMPD1 PTGS1 B4GALT6 ART4 TMEM108 CDH4 SLC4A11 FOXC2	1.40e-07	191	190	9	4bfdf44d4402a42530d30c89d94946acdda4321b
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A3 GALNT2 NRCAM FAT3 CHSY1 PTPRG SSH1 PAPPA TMEM108	1.40e-07	191	190	9	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A3 MYH10 FAT3 NFASC PTPRG TMEM108 CDH4 TNXB ADAMTSL2	1.53e-07	193	190	9	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	COL6A3 MYH10 NRCAM FAT3 NFASC ABCA8 PTPRG TMEM108 TNXB	1.68e-07	195	190	9	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Pvalb\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GAD2 HCN1 FRMPD1 NEK7 BTBD3 BTN2A2 AFAP1 MYBPC1	5.18e-07	163	190	8	db6b7ce6f7221bb73c5e650ac51cdd5d7ef00675
ToppCell	Basal\|World / shred by cell class for mouse tongue	CACHD1 JAG2 SLC6A6 ASAP2 AFAP1 HS6ST1 PAPPA TRPV4	1.24e-06	183	190	8	c6729a207526ff4aa48176207b9353176f631fea
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 MAN1A1 HDAC4 ASAP2 HS6ST1 PAPPA TRPV4 BCAR3	1.58e-06	189	190	8	3a295c215b5c18e7c673f92b7af5be523421682c
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 MYH10 FAT3 NFASC ABCA8 PTPRG TMEM108 TNXB	1.71e-06	191	190	8	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 MYH10 FAT3 NFASC ABCA8 PTPRG TMEM108 TNXB	1.78e-06	192	190	8	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 COL12A1 SHOX ABCA8 PTPRG PAPPA TMEM108 FOXC2	1.85e-06	193	190	8	6ef9007c9d18fb775d08fb20cdf954a28d54d7eb
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 COL12A1 SHOX ABCA8 PTPRG PAPPA TMEM108 FOXC2	1.85e-06	193	190	8	e4ea7ce011a80b81b841c907719aa532bed39d2e
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 COL12A1 SHOX ABCA8 PTPRG PAPPA TMEM108 FOXC2	1.85e-06	193	190	8	cf2461af78f65616ce40d552ee9452295e3895ed
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 MAN1A1 NRCAM PTGS1 HS6ST1 PAPPA TRPV4 LRBA	1.92e-06	194	190	8	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 MAN1A1 NRCAM PTGS1 HS6ST1 PAPPA TRPV4 LRBA	1.92e-06	194	190	8	69bff17df4a760ccf081cf52ff04af02c14f448d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 MYH10 NRCAM FAT3 ABCA8 AFAP1 PAPPA TMEM108	1.92e-06	194	190	8	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	(5)_Fibroblast-C_(Myofibroblast)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	COL6A3 MYH10 FAT3 ABCA8 EGFL6 AOC3 TMEM108 ADAMTSL2	1.92e-06	194	190	8	29a72e565c19407bbd198cfbc2a78106fe830d05
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	COL6A3 MYH10 FAT3 NFASC ABCA8 TMEM108 HS3ST2 ADAMTSL2	2.00e-06	195	190	8	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 MAN1A1 METRNL CAPG HS6ST1 SLC39A6 PAPPA CTSD	2.00e-06	195	190	8	0ac7762197cdd8d643f87148573a8df6e936c1b0
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 MYH10 FAT3 NFASC ABCA8 PTPRG TMEM108 TNXB	2.07e-06	196	190	8	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	368C-Fibroblasts-Fibroblast-G\|368C / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 MYH10 FAT3 EGFL6 AOC3 TMEM108 TNXB ADAMTSL2	2.15e-06	197	190	8	156155c2f0c1a2461e45803da578af18ee221660
ToppCell	normal_Lung-Fibroblasts-COL13A1+_matrix_FBs\|normal_Lung / Location, Cell class and cell subclass	COL6A3 MYH10 FAT3 NFASC ABCA8 AOC3 TNXB ADAMTSL2	2.15e-06	197	190	8	6c57ab2efb8363828e24211c4d45e58bb73a9a4d
ToppCell	368C-Fibroblasts-Fibroblast-G-\|368C / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 MYH10 FAT3 EGFL6 AOC3 TMEM108 TNXB ADAMTSL2	2.15e-06	197	190	8	d5d9263451f6c10cb3b9c17740183ca334e24851
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	COL6A3 MYH10 COL12A1 NRCAM AFAP1 PTPRG PAPPA TMEM108	2.15e-06	197	190	8	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|367C / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 MYH10 FAT3 ABCA8 EGFL6 AOC3 TMEM108 ADAMTSL2	2.24e-06	198	190	8	a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 MYH10 FAT3 ABCA8 EGFL6 AOC3 TMEM108 ADAMTSL2	2.24e-06	198	190	8	7b5350768f306ec528e271d2ac4470bf668ec6f0
ToppCell	distal-2-mesenchymal-Airway_Smooth_Muscle\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FLNC MYH10 COL12A1 NFASC EGFL6 AOC3 PAPPA FOXC2	2.32e-06	199	190	8	af226a6c50747dad9ca696463e715913b3ac17c0
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 MYH10 FAT3 NFASC ABCA8 PTPRG PAPPA TNXB	2.41e-06	200	190	8	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	10x3'2.3-week_12-13-Mesenchymal_fibro\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 FLNC COL12A1 ABCA8 EGFL6 PTPRG ASS1 TNXB	2.41e-06	200	190	8	76f3043cb88071256ff661885fe5a82a54f5b733
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 MYH10 FAT3 NFASC ABCA8 TMEM108 TNXB ADAMTSL2	2.41e-06	200	190	8	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	10x3'2.3-week_12-13-Mesenchymal_fibro-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 FLNC COL12A1 ABCA8 EGFL6 PTPRG ASS1 TNXB	2.41e-06	200	190	8	64d2941689d7ca8af54f9ba21c5aeabf719084ef
ToppCell	COPD-Epithelial-PNEC\|World / Disease state, Lineage and Cell class	ANO4 NRCAM NFASC RNF183 OTOS TAGLN3 TMEM108	5.80e-06	160	190	7	cdea93317b0ebb801ddbe73bca6149ce2c727f16
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	HCN1 FRMPD1 NEK7 BTBD3 BTN2A2 AFAP1 MYBPC1	7.10e-06	165	190	7	d8df50f5a3b646e8ea13739fdc65ce6f39b4d4d2
ToppCell	facs-Skin-Anagen-24m-Epithelial-epidermal_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTLC3 NAT8L METRNL GDPD2 TMPRSS4 PTGS1 HEPHL1	7.68e-06	167	190	7	02c89069dcd0e87f7502e32b14e7cbd3cab81a09
ToppCell	facs-Spleen-nan-3m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GALNT2 DUSP5 CHSY1 ITGAL RACGAP1 UHRF1 CTSD	7.98e-06	168	190	7	74dc46738f1d0a448df6c9b8288b515d92697792
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 COL12A1 NFASC ABCA8 ART4 SLC15A5 TNXB	8.63e-06	170	190	7	03044e1436443b28dd39d5ef4fdb25c18e3a7546
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 COL12A1 NFASC ABCA8 ART4 SLC15A5 TNXB	8.63e-06	170	190	7	fa753cc8fbd04e63c9a303da4dc17ee2ce907f92
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYH10 COL12A1 NRCAM PTPRG PAPPA TNXB	1.04e-05	175	190	7	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYH10 FAT3 NFASC AOC3 TNXB ADAMTSL2	1.16e-05	178	190	7	09475e522dc1b8cf9ff1c25de5d1e3082b162948
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYH10 FAT3 NFASC AOC3 TNXB ADAMTSL2	1.16e-05	178	190	7	000d25f3f13cc76cf39c46c312c6fafc2ea4f368
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ABCA4 MAN1A1 PTGS1 PTPRK SLC22A10 BCAR3 HS3ST2	1.16e-05	178	190	7	731e1e8eff2c4018c75dfc66632a316010a09a9a
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPNS1 CAPG OSCAR PNPLA6 GLA AOC3 CTSD	1.16e-05	178	190	7	0b398656f26c4061b11ccf98908d0e2e1367585a
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYH10 FAT3 NFASC AOC3 TNXB ADAMTSL2	1.16e-05	178	190	7	35de8f791b0e78a6caf52ff095f05e204a59e828
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM FAT3 ITPRID1 ABCA8 AFAP1 TMEM108 TNXB	1.25e-05	180	190	7	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 HDAC4 ASAP2 HS6ST1 PAPPA TRPV4 BCAR3	1.25e-05	180	190	7	023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM FAT3 ITPRID1 ABCA8 AFAP1 TMEM108 TNXB	1.25e-05	180	190	7	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MORC1 SPTLC3 MDM1 RNF183 ACOX2 CFAP52 LRRC23	1.25e-05	180	190	7	5c9d2d44d840cd4ec7d42d43446ba2b689e7ec43
ToppCell	PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MORC1 SPTLC3 MDM1 RNF183 ACOX2 CFAP52 LRRC23	1.25e-05	180	190	7	c60e74fbbd815a0251253a19dc520a254b2e1762
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 COL12A1 NFASC ABCA8 PAPPA TNXB CNGA3	1.34e-05	182	190	7	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 SPTLC3 FAT3 AFAP1 PAPPA TNXB FOXC2	1.39e-05	183	190	7	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	facs-Skin-nan-18m-Epithelial-epidermal_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTLC3 NAT8L METRNL DUSP5 TMPRSS4 NIBAN2 PTGS1	1.44e-05	184	190	7	dc7f6ee4062856a02423fff8b1cce62d46a9355c
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL6A3 MYH10 COL12A1 NFASC ABCA8 ART4 ADAMTSL2	1.60e-05	187	190	7	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	COL6A3 MYH10 PTPRG PAPPA TMEM108 TNXB ADAMTSL2	1.60e-05	187	190	7	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	ANO4 COL6A3 MYH10 NRCAM FAT3 PTPRG TNXB	1.60e-05	187	190	7	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	BTBD3 EGFL6 AOC3 PAPPA TAGLN2 BCAR3 FOXC2	1.60e-05	187	190	7	1aebf6fab40b96f2f5feb77a302bb805838fccf3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 HDAC4 ASAP2 HS6ST1 PAPPA TRPV4 BCAR3	1.60e-05	187	190	7	e3095455d2f255854f339f6b05fa87852af0700f
ToppCell	droplet-Fat-Scat-21m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAT8L COL6A3 FLNC AR SEMA3B PAX1 TNXB	1.66e-05	188	190	7	7fc9810ab14354cb512e2b1285562009c10203f5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 HDAC4 NRCAM ASAP2 HS6ST1 PAPPA BCAR3	1.66e-05	188	190	7	e30a4ddac0da8cdcf621d98e28e3895cd9307e7a
ToppCell	droplet-Fat-Scat-21m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAT8L COL6A3 FLNC AR SEMA3B PAX1 TNXB	1.66e-05	188	190	7	e54e09d34e263d5709c337914809e61e74e20591
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	COL6A3 MYH10 FAT3 NFASC ABCA8 PTPRG TNXB	1.77e-05	190	190	7	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	Control-Endothelial-VE_Venous\|Endothelial / Disease state, Lineage and Cell class	CHSY1 CACHD1 PTGS1 AFAP1 PTPRG SSH1 ASS1	1.77e-05	190	190	7	4e30155203b4a8c5e496fcbe9348b67b98ebc625
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 HDAC4 NRCAM ASAP2 HS6ST1 PAPPA BCAR3	1.77e-05	190	190	7	11d3c31167ea71809b4cc3757a0c6ea54a448602
ToppCell	facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAT8L COL6A3 SLC25A42 COL12A1 HCN1 CDH4 ADAMTSL2	1.77e-05	190	190	7	c7bd087f36321cec61b98657433b4d19d135791f
ToppCell	facs-Lung-nan-3m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAT8L COL6A3 SLC25A42 COL12A1 HCN1 CDH4 ADAMTSL2	1.77e-05	190	190	7	834218fcc59df5e7e52de154272f3d55d81d0dac
ToppCell	renal_papilla_nuclei-Adult_normal_reference\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 MAN1A1 NRCAM FAT3 PTGS1 LRBA SLC4A11	1.90e-05	192	190	7	6c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 MAN1A1 PTGS1 HS6ST1 SLC39A6 PAPPA TRPV4	1.90e-05	192	190	7	40f44ac4ab673ee6156abdd2074a60b9de3281ad
ToppCell	COVID-19-kidney-CD-PC\|kidney / Disease (COVID-19 only), tissue and cell type	MYH10 HDAC4 NRCAM ASAP2 HS6ST1 PAPPA TRPV4	1.96e-05	193	190	7	738689d009e4b118d7ce3171a207294b95cbe78b
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	DUSP5 CHSY1 PTGS1 ASAP2 ART4 TMEM108 HS3ST2	1.96e-05	193	190	7	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	droplet-Heart-HEART-1m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC PTGS1 B4GALT6 OTOS TMEM108 CDH4 FOXC2	1.96e-05	193	190	7	d0a5f212f8e8a13dbbe3e41df92548ef82eef70b
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A3 MYH10 FAT3 PTPRG TMEM108 TNXB ADAMTSL2	1.96e-05	193	190	7	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 MYH10 NRCAM FAT3 ABCA8 AFAP1 TMEM108	1.96e-05	193	190	7	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A3 MYH10 FAT3 PTPRG TMEM108 TNXB ADAMTSL2	2.03e-05	194	190	7	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 MAN1A1 PTGS1 HS6ST1 SLC39A6 PAPPA TRPV4	2.03e-05	194	190	7	4d6c9b016e3a0641954a8ea10c97d1cd76fadd9f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 MAN1A1 PTGS1 HS6ST1 SLC39A6 PAPPA TRPV4	2.03e-05	194	190	7	be869e186386d03ebb670971dd24fa656b4b0edf
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANO4 COL6A3 MYH10 COL12A1 NRCAM PAPPA TNXB	2.03e-05	194	190	7	8fae8061b350336299aa81f378e07deadbd55123
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A3 MYH10 FAT3 ABCA8 PTPRG AOC3 TMEM108	2.03e-05	194	190	7	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 MYH10 NRCAM FAT3 ABCA8 AFAP1 TMEM108	2.03e-05	194	190	7	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 COL12A1 NFASC ABCA8 ART4 TNXB ADAMTSL2	2.03e-05	194	190	7	e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANO4 COL6A3 MYH10 COL12A1 NRCAM PAPPA TNXB	2.03e-05	194	190	7	4d7d24390fdb379f943ddcc70a63f23955e10163
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAT8L COL6A3 SLC25A42 COL12A1 HCN1 CDH4 ADAMTSL2	2.10e-05	195	190	7	c6bb16c0076639c6ddef1a15d8cba44bc29c077d
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYH10 FAT3 ABCA8 AOC3 TNXB ADAMTSL2	2.10e-05	195	190	7	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	COL6A3 MYH10 FAT3 NFASC ABCA8 TMEM108 TNXB	2.10e-05	195	190	7	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYH10 FAT3 ABCA8 AOC3 TNXB ADAMTSL2	2.10e-05	195	190	7	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 COL12A1 NFASC ABCA8 ART4 TNXB ADAMTSL2	2.10e-05	195	190	7	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAT8L COL6A3 SLC25A42 COL12A1 HCN1 CDH4 ADAMTSL2	2.10e-05	195	190	7	ea89f80d3d7e9f737442f7c1aa1791d277ffc90c
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NIBAN2 CCDC6 HDAC3 PTPRK PURA ASS1 SLC4A11	2.17e-05	196	190	7	547901c7a665770eff78eede69b8625b416c8186
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 METRNL CAPG HS6ST1 SLC39A6 PAPPA CTSD	2.17e-05	196	190	7	cd8c22c6f52f068a33525723108d6b5b23fe822d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FLNC MYH10 COL12A1 NFASC EGFL6 AOC3 FOXC2	2.17e-05	196	190	7	70b2e0b4ff4f1bc03fb72ace07a8a44f4b415922
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MYH10 FAT3 EGFL6 AOC3 TMEM108 TAGLN2 ADAMTSL2	2.17e-05	196	190	7	6730743cf088c419ccc2d28765769fc09d3ba6a7
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MYH10 FAT3 EGFL6 AOC3 TMEM108 TAGLN2 ADAMTSL2	2.17e-05	196	190	7	21dab89f3699037138a9c7a0e4dc98739a9fad9c
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYH10 FAT3 ABCA8 AOC3 TNXB ADAMTSL2	2.17e-05	196	190	7	9737a5f006d37b549f281e1863aca558e1e4dc99
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FLNC MYH10 COL12A1 NFASC EGFL6 AOC3 FOXC2	2.17e-05	196	190	7	ac4c8571bd792538f8df7b9bdd90ef58405fd3b1
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYH10 FAT3 ABCA8 AOC3 TNXB ADAMTSL2	2.17e-05	196	190	7	42e9828222a9663525d571633e8a454c30bfa7f8
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FLNC MYH10 COL12A1 NFASC EGFL6 AOC3 FOXC2	2.17e-05	196	190	7	208ddedd29e1b9ca89cbb9b527c2e193a44cada2
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYH10 FAT3 ABCA8 AOC3 TNXB ADAMTSL2	2.17e-05	196	190	7	cecf82cd5e0a3835d655f5e7478578674a63ce25
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NIBAN2 CCDC6 HDAC3 PTPRK PURA ASS1 SLC4A11	2.17e-05	196	190	7	6e08d7ba67da161c2dca1a17c440ffb9d9b5bc3b
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A3 MYH10 NRCAM ABCA8 AFAP1 PAPPA TNXB	2.24e-05	197	190	7	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 COL12A1 NFASC ABCA8 ART4 CHST7 ADAMTSL2	2.24e-05	197	190	7	09946ee8dfb15a2a32da06e5b331f3277ee934f4
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPNS1 CAPG OSCAR PNPLA6 GLA TAGLN2 CTSD	2.24e-05	197	190	7	4f022bae7af2ca23689cc0d35046a7e23dba6e9c
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TMPRSS4 CACHD1 AR JAG2 TRPV4 PAX1 SLC4A11	2.24e-05	197	190	7	107cb153ea7fc74bbd244dbb9d0499c0a8506724
Disease	Liver carcinoma	MPO IRF2 TERT AR CELSR3 BRAF SLC22A10 RACGAP1 UHRF1 TAGLN2 CTSD TATDN1	9.76e-05	507	186	12	C2239176
Disease	Thyroid carcinoma	TERT DICER1 BRAF PRKAR1A	1.70e-04	44	186	4	C0549473
Disease	response to cyclophosphamide, response to antineoplastic agent	NEK7 HS3ST2	2.35e-04	4	186	2	GO_0097327, GO_1902518
Disease	Ullrich congenital muscular dystrophy	COL6A3 COL12A1	2.35e-04	4	186	2	cv:C4551860
Disease	Bulbospinal Neuronopathy	AR TRPV4	2.35e-04	4	186	2	C0393547
Disease	Bethlem myopathy	COL6A3 COL12A1	2.35e-04	4	186	2	cv:C1834674
Disease	BETHLEM MYOPATHY 1	COL6A3 COL12A1	2.35e-04	4	186	2	C1834674
Disease	Ullrich congenital muscular dystrophy 1	COL6A3 COL12A1	2.35e-04	4	186	2	C0410179
Disease	Bethlem myopathy (is_implicated_in)	COL6A3 COL12A1	2.35e-04	4	186	2	DOID:0050663 (is_implicated_in)
Disease	Ullrich congenital muscular dystrophy (is_implicated_in)	COL6A3 COL12A1	2.35e-04	4	186	2	DOID:0050558 (is_implicated_in)
Disease	3b-hydroxy-5-cholenoic acid measurement	ADCK5 SLC27A5	2.35e-04	4	186	2	EFO_0800348
Disease	monocyte percentage of leukocytes	MPO GAD2 SUPT3H RASA2 METRNL CHSY1 CHD7 CCDC6 TERT EGFL6 BAIAP2L1 CCR3 WDFY3 EXOC3L2	2.38e-04	731	186	14	EFO_0007989
Disease	Malignant neoplasm of thyroid	BRAF PRKAR1A	3.90e-04	5	186	2	C0007115
Disease	Colorectal Neoplasms	FLNC ABCA4 STARD8 NRCAM ABCA8 PGM1 BRAF ABCD4	3.95e-04	277	186	8	C0009404
Disease	lymphocyte:monocyte ratio	GAD2 SUPT3H RASA2 METRNL HS6ST1 CCR3 BCAR3 EXOC3L2	5.10e-04	288	186	8	EFO_0600088
Disease	myeloperoxidase measurement	MPO GALNT2 TNXB	5.76e-04	26	186	3	EFO_0005243
Disease	Melanoma, Cloudman S91	BRAF KDM1A	8.13e-04	7	186	2	C0009075
Disease	Melanoma, B16	BRAF KDM1A	8.13e-04	7	186	2	C0004565
Disease	Melanoma, Experimental	BRAF KDM1A	8.13e-04	7	186	2	C0025205
Disease	retinal detachment	FAT3 GRM5	8.13e-04	7	186	2	EFO_0005773
Disease	Melanoma, Harding-Passey	BRAF KDM1A	8.13e-04	7	186	2	C0018598
Disease	MASA syndrome (implicated_via_orthology)	NRCAM NFASC	8.13e-04	7	186	2	DOID:0060246 (implicated_via_orthology)
Disease	melanoma	RASA2 TRRAP TERT BRAF PTPRK FTO KDM1A	1.04e-03	248	186	7	C0025202
Disease	Familial melanoma	TERT BRAF	1.08e-03	8	186	2	cv:C1512419
Disease	Malignant melanoma of skin	TERT BRAF	1.08e-03	8	186	2	cv:C0151779
Disease	Melanoma	TERT BRAF	1.08e-03	8	186	2	cv:C0025202
Disease	melanoma (is_implicated_in)	TERT BRAF ASS1	1.28e-03	34	186	3	DOID:1909 (is_implicated_in)
Disease	Prostatic Cancer, Castration-Resistant	AR KDM1A	1.38e-03	9	186	2	C3658266
Disease	Prostatic Neoplasms, Castration-Resistant	AR KDM1A	1.38e-03	9	186	2	C3658267
Disease	1-ribosyl-imidazoleacetate measurement	EEF1D PRKAR1A	1.38e-03	9	186	2	EFO_0800034
Disease	retinal degeneration (is_implicated_in)	ABCA4 HDAC4	1.38e-03	9	186	2	DOID:8466 (is_implicated_in)
Disease	familial melanoma (is_implicated_in)	TERT BRAF	1.38e-03	9	186	2	DOID:6846 (is_implicated_in)
Disease	aplastic anemia (is_marker_for)	TERT ANAPC2	1.38e-03	9	186	2	DOID:12449 (is_marker_for)
Disease	Disproportionate short stature	TCTN3 SHOX PRKAR1A TRPV4	1.45e-03	77	186	4	C0878659
Disease	Thyroid Neoplasm	TERT BRAF PRKAR1A	1.64e-03	37	186	3	C0040136
Disease	aspartate aminotransferase measurement	ANO4 CACNA1S ABCA4 GALNT2 ACOX2 SNX13 TRAPPC13 CCR3 CCR8 LRBA HEPHL1 FTO CTSD GOT2	1.86e-03	904	186	14	EFO_0004736
Disease	urate measurement, bone density	SPTLC3 ABCA8 HMG20A PTPRG MOV10L1 ASS1 TMEM108 FTO CDH4 TNXB SLC4A11	2.00e-03	619	186	11	EFO_0003923, EFO_0004531
Disease	Breast Carcinoma	STARD8 NRCAM TERT PTGS1 AR JAG2 BRAF SLC39A6 BCAR3 FTO	2.30e-03	538	186	10	C0678222
Disease	neutrophil count, eosinophil count	MPO RASA2 CHSY1 CHD7 TERT EXOC3L2	2.38e-03	213	186	6	EFO_0004833, EFO_0004842
Disease	Oligospermia	PIWIL4 DICER1	2.50e-03	12	186	2	C0028960
Disease	myeloid white cell count	MPO GAD2 RASA2 ACADS METRNL CHSY1 CHD7 ITGAL TERT SNX13 JAG2 BAIAP2L1 BCAR3 EXOC3L2	2.58e-03	937	186	14	EFO_0007988
Disease	neutrophil count	MPO RASA2 NEK7 CHSY1 RNF183 CHD7 ITGAL TERT EGFL6 SNX13 HMG20A JAG2 BAIAP2L1 UHRF1 LRBA EXOC3L2 FTO TNXB	2.94e-03	1382	186	18	EFO_0004833
Disease	neutrophil count, basophil count	MPO RASA2 CHSY1 CHD7 TERT EXOC3L2	3.06e-03	224	186	6	EFO_0004833, EFO_0005090
Disease	neuroticism measurement, cognitive function measurement	GALNT2 HCN1 GRM5 PTPRK UHRF1 RAB11FIP5 SLC15A5 FTO PUS7 MAST3	3.30e-03	566	186	10	EFO_0007660, EFO_0008354
Disease	neuronal ceroid lipofuscinosis (implicated_via_orthology)	SPNS1 CTSD	3.42e-03	14	186	2	DOID:14503 (implicated_via_orthology)
Disease	lymphocyte percentage of leukocytes	MPO CACNA1S GAD2 CHSY1 CHD7 TERT TMTC3 BAIAP2L1 HS6ST1 LMAN2 EXOC3L2	3.45e-03	665	186	11	EFO_0007993
Disease	Alopecia, Male Pattern	AR PRKAR1A	3.93e-03	15	186	2	C4083212
Disease	schizophrenia (biomarker_via_orthology)	KDM1A GOT2	3.93e-03	15	186	2	DOID:5419 (biomarker_via_orthology)
Disease	Androgenetic Alopecia	AR PRKAR1A	3.93e-03	15	186	2	C0162311
Disease	Female pattern alopecia (disorder)	AR PRKAR1A	3.93e-03	15	186	2	C0263477
Disease	Weight Gain	METRNL NEK7 FTO CTSD	4.02e-03	102	186	4	C0043094
Disease	risky sexual behaviour measurement	HCN1 NFASC SLC15A5 FTO MAST3	4.44e-03	169	186	5	EFO_0007877
Disease	Spondyloepiphyseal Dysplasia	TRPV4 ADAMTSL2	4.47e-03	16	186	2	C0038015
Disease	Tetralogy of Fallot	NKX2-6 FOXC2	4.47e-03	16	186	2	C0039685
Disease	Spondyloepiphyseal Dysplasia Tarda, X-Linked	TRPV4 ADAMTSL2	4.47e-03	16	186	2	C3541456
Disease	Schwartz-Jampel Syndrome, Type 1	TRPV4 ADAMTSL2	4.47e-03	16	186	2	C4551479
Disease	Abnormal behavior	TRPV4 PUS7	4.47e-03	16	186	2	C0233514
Disease	Schwartz-Jampel Syndrome	TRPV4 ADAMTSL2	4.47e-03	16	186	2	C0036391
Disease	Melnick-Needles Syndrome	TRPV4 ADAMTSL2	4.47e-03	16	186	2	C0025237
Disease	Major Depressive Disorder	MORC1 MPO GAD2 GRM5 TERT HTR3B	4.55e-03	243	186	6	C1269683
Disease	Inborn Errors of Metabolism	ABCD4 ADAMTSL2	5.05e-03	17	186	2	C0025521
Disease	Van Buchem disease	TRPV4 ADAMTSL2	5.05e-03	17	186	2	C0432272
Disease	Colorectal Carcinoma	MPO RALGDS FLNC ABCA4 STARD8 NRCAM ITPRID1 ABCA8 PGM1 BRAF ABCD4	5.15e-03	702	186	11	C0009402
Disease	granulocyte count	MPO RASA2 CHSY1 CHD7 TERT EXOC3L2	5.62e-03	254	186	6	EFO_0007987
Disease	Adrenocortical carcinoma	TERT BRAF	5.66e-03	18	186	2	C0206686
Disease	hepatocellular carcinoma (is_implicated_in)	MPO MCM7 TERT DICER1 ASS1	5.92e-03	181	186	5	DOID:684 (is_implicated_in)
Disease	Prostatic Neoplasms	MPO CHD7 TERT AR FAF2 THYN1 BRAF PTPRK USP7 CTSD	5.93e-03	616	186	10	C0033578
Disease	Malignant neoplasm of prostate	MPO CHD7 TERT AR FAF2 THYN1 BRAF PTPRK USP7 CTSD	5.93e-03	616	186	10	C0376358
Disease	conotruncal heart malformations	NFASC TULP4 SLC22A10 PAPPA	5.95e-03	114	186	4	MONDO_0016581
Disease	Drug habituation	ANO4 NRCAM GRM5 BCAR3	6.14e-03	115	186	4	C0013170
Disease	Drug abuse	ANO4 NRCAM GRM5 BCAR3	6.14e-03	115	186	4	C0013146
Disease	Prescription Drug Abuse	ANO4 NRCAM GRM5 BCAR3	6.14e-03	115	186	4	C4316881
Disease	Substance-Related Disorders	ANO4 NRCAM GRM5 BCAR3	6.14e-03	115	186	4	C0236969
Disease	Drug Use Disorders	ANO4 NRCAM GRM5 BCAR3	6.14e-03	115	186	4	C0013222
Disease	Drug Dependence	ANO4 NRCAM GRM5 BCAR3	6.14e-03	115	186	4	C1510472
Disease	Substance Dependence	ANO4 NRCAM GRM5 BCAR3	6.14e-03	115	186	4	C0038580
Disease	Substance Use Disorders	ANO4 NRCAM GRM5 BCAR3	6.14e-03	115	186	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	ANO4 NRCAM GRM5 BCAR3	6.14e-03	115	186	4	C0029231
Disease	Noonan-Like Syndrome With Loose Anagen Hair	RASA2 BRAF	6.30e-03	19	186	2	C3501846
Disease	Noonan syndrome-like disorder with loose anagen hair	RASA2 BRAF	6.30e-03	19	186	2	C1843181
Disease	Osteochondrodysplasias	TRPV4 ADAMTSL2	6.30e-03	19	186	2	C0029422
Disease	Cardio-facio-cutaneous syndrome	RASA2 BRAF	6.30e-03	19	186	2	C1275081
Disease	Costello syndrome (disorder)	RASA2 BRAF	6.30e-03	19	186	2	C0587248
Disease	Dyschondroplasias	TRPV4 ADAMTSL2	6.30e-03	19	186	2	C0013366
Disease	Pseudopelade	AR PRKAR1A	6.30e-03	19	186	2	C0086873
Disease	Alopecia	AR PRKAR1A	6.30e-03	19	186	2	C0002170

Protein segments in the cluster

Peptide	Gene	Start	Entry
NGRRFPVEMQIFFYN	PTPRG	166	P23470
GAQALALRRMQDEPY	EXOC3L2	206	Q2M3D2
NMLSRFAQVLPDGTY	ACOX2	266	Q99424
NRDQIIFMVGRGYLS	BRAF	661	P15056
RNQAGYFMLPTVITD	ALDH8A1	366	Q9H2A2
RDNAIGFYMAVPALA	EGFL6	426	Q8IUX8
PRTFQEMIQRLYGCF	ANAPC2	166	Q9UJX6
YGNNTMRTPNIDRLA	ARSL	56	P51690
GNFPGSVQRERHYNM	ABCA4	2191	P78363
VNYAENRMAFGAPLT	ACADS	291	P16219
SYRMNAERILAGFQP	BCAR3	756	O75815
YTVFRVNMSNQVPRS	HTR3B	281	O95264
THDQIMRRYGEQPAS	AKIRIN2	186	Q53H80
CFMNRRVISANPYLG	AFAP1	471	Q8N556
VGRFYTNLPNRMIDE	CACHD1	436	Q5VU97
GLYPTIRERNAMMFN	BTBD3	101	Q9Y2F9
VAMINRQEIGGPRSY	GLA	351	P06280
RRDRQAFSMYEPGSA	GIT1	501	Q9Y2X7
NVALGAPVDRYFLMA	ADCK5	491	Q3MIX3
YFNEMSAQGLRPRTV	CCDC6	336	Q16204
HMQIRVNAEPAAFYR	ABCD4	226	O14678
VLGRYAEQMNVRMPF	ANO4	171	Q32M45
GRARAPISNYIMLAD	DICER1	551	Q9UPY3
RRQMFDFQGLIPGYT	CHD7	2336	Q9P2D1
AERRFYEQMNGPVAG	EEF1D	21	P29692
RMPEFYNRFKGRNDL	ASS1	146	P00966
RGYRIQMLSFAGEPL	AOC3	601	Q16853
PYFQQTGVRGFARSM	PGM1	321	P36871
FQYLRMDAEPRGSEV	NKX2-6	41	A6NCS4
SARAMIPRQRYDFTG	PGBD4	76	Q96DM1
IFYSLRQMATQRFPN	RASA2	481	Q15283
YSDEANQMRVAPPRA	RAB11FIP5	306	Q9BXF6
LQGPMQAAYREAFQS	EDC4	1106	Q6P2E9
KGNNAFRVYRMLPLS	IRF2	101	P14316
GPAFTDAIRMYRQSK	NIBAN2	206	Q96TA1
RFASVFYTNVVPMLN	OR8B4	271	Q96RC9
PLNSFQYQRRQAMGI	MORC1	466	Q86VD1
SMGLQLYGFRQRQRA	PEX10	231	O60683
MVFQRLGQGDYVFRP	PNPLA6	211	Q8IY17
GYINNLPADIARSMG	PNPLA6	1136	Q8IY17
SYQPLGDKVNFFRMV	GAD2	546	Q05329
YFVTQEAPRRIFNMS	HS3ST2	181	Q9Y278
MSGPRAGFYRQELNK	MAPK11	1	Q15759
KYFMRVVPSDAQQAR	GRM5	186	P41594
RNYQASMEAAGIPVS	HDAC4	606	P56524
LMSRPAYQRDENAFG	MOV10L1	941	Q9BXT6
ERVFPYISVMVNNGS	LMAN2	171	Q12907
QPEYAVVQRGSMVSF	NRCAM	551	Q92823
MDIENPNLYGRFRQL	ITPRID1	191	Q6ZRS4
RFEKGMQPRQSVTDY	MTMR7	506	Q9Y216
PLTGYVRFMNERREQ	HMG20A	106	Q9NP66
RAAYNVTLLNFMDPQ	FTO	196	Q9C0B1
VQAARPMGYFELQLS	JAG2	21	Q9Y219
RAFMPSILQNETYGA	ASAP2	751	O43150
PSFQRYSMQGEEARA	ATXN1L	651	P0C7T5
MVRSGQDPYARNKFN	GALNT2	91	Q10471
FAPETGRLMYVINNA	CFAP52	401	Q8N1V2
FRYMAENPTAGVVQE	DDX42	161	Q86XP3
DGNRLRSAQMNELPY	LRRC23	121	Q53EV4
TAREISMRVRFFPYN	PDZD11	116	Q5EBL8
MVYGSEEPLARNLRN	MPO	341	P05164
ALRPDMGYNTLANFR	NEK7	21	Q8TDX7
LYNRIFRNSFLMGPV	KIR3DL3	71	Q8N743
PGAGRYTIMVLFANQ	FLNC	836	Q14315
MPVRFKGLSEYQRNF	MDM1	1	Q8TC05
MIPAFDQRNGLRVIY	LRBA	711	P50851
NFNIAGTVVKYRRPM	ADAMTSL2	276	Q86TH1
ANVQRRAPGMRQIYG	GDPD2	396	Q9HCC8
MQARYSVSDPNALGV	FOXC2	1	Q99958
FQRMYRDAQERGLNP	METRNL	291	Q641Q3
TNVNSRMLYFAPDLV	AR	756	P10275
MYRVNVAENLPAGSS	PCDHGB3	246	Q9Y5G1
LRAYFSQPMVAAAVI	PAPPA	1086	Q13219
EMRLQPFNEYRKRFG	PTGS1	456	P23219
NPVLYAAMNRQFRQA	GPR84	366	Q9NQS5
AAMNRQFRQAYGSIL	GPR84	371	Q9NQS5
KFIRPFMQYNSTRAG	HS6ST1	311	O60243
YIDFLQRVSPTNMQG	HDAC3	66	O15379
SPQNQYPAELMRRFE	MCM7	121	P33993
MRRFELYFQGPSSNK	MCM7	131	P33993
NMSFVLYREGVAAPL	OSCAR	156	Q8IYS5
FYIRDGMSVRVAPQG	PARD6A	171	Q9NPB6
RNYFQRMGQPQITVR	MYO15B	971	Q96JP2
MNATSAFGPNLRYIV	NFASC	751	O94856
ARQLAGPLAMEQTYG	PAX1	86	P15863
ALGAYPQIEDMARTF	OTOS	56	Q8NHW6
FYGNRSAGSMQRPRA	CCSER2	176	Q9H7U1
AMVQFDRYLSAPDNL	COG6	581	Q9Y2V7
MPEQSNDYRVVVFGA	DIRAS1	1	O95057
NNLMPYVSQVAIGRR	GALE	206	Q14376
AERRFYEQMNGPVAG	EEF1DP3	21	Q658K8
RSRYMQCQSIFGPDA	ADAM30	501	Q9UKF2
GPRRQYGFMQRQFTS	HCN1	86	O60741
ADQFLGAMYTLPRQA	KDM1A	826	O60341
AASPYFRAMFAGQLR	KLHL21	56	Q9UJP4
YRNVMEQFNPGLRNL	BAIAP2L1	16	Q9UHR4
PGIANTYLFMVQARG	B4GALT6	36	Q9UBX8
MNPVIYAFVGERFRK	CCR3	296	P51677
PVSGGKRQEFYVSRM	COL12A1	1421	Q99715
TARQYALDRMQFGVP	GCDH	311	Q92947
VGPIYNNRVEMAIFF	CACNA1S	1031	Q13698
QIFNYLGRQMPRESC	CCR8	321	P51685
YGGRIFNATLMLQDR	FRMPD1	396	Q5SYB0
DGILGMAYPRISVNN	CTSD	196	P07339
GKTNFPYVRDFVMNL	COL6A3	651	P12111
PNNFDIEAAMRRYPT	DNAH7	3761	Q8WXX0
NAPQFMTVEYRASVR	FAT3	2596	Q8TDW7
NRQLLEEMPRFYGSR	BIN3	176	Q9NQY0
KYRRGQMDLDFPSNL	CCDC183	261	Q5T5S1
RFMQQAVRYSKLSDP	CDH4	536	P55283
AYVQLNMPGSDLERR	RALGDS	226	Q12967
NRDPSEQRYGMIRTF	HEPHL1	721	Q6MZM0
QMEGRLQEFLTAYAP	MAST3	186	O60307
SYNRTFMKLGPEAFR	MAN1A1	511	P33908
SDYFGEIALLMNRPR	PRKAR1A	321	P10644
FRPAAMLVERSTDYG	LAMB4	136	A4D0S4
QVAEGFISRMQYAPN	CAPG	311	P40121
MDRSLRSVFVGNIPY	CSTF2T	11	Q9H0L4
QVEPRNVDRGAMRFY	CELSR3	2631	Q9NYQ7
RRNITMVSYLEDFPG	HPS1	526	Q92902
EMFGNQYRALSSPER	BTN2A2	421	Q8WVV5
FRALLYGGMRESQPE	BTBD9	61	Q96Q07
YRFVPSNVRGTSMNF	SLC15A5	456	A6NIM6
DYIKQRRSMVSPNFG	DUSP5	291	Q16690
MAQRTGLEDPERYLF	MYH10	1	P35580
ANPYEMIRGVFFLNR	CMTR1	221	Q8N1G2
NAALMDSYRQPAAFI	PTPRK	1231	Q15262
NPFIYSLRNRDMRGN	OR1E3	286	Q8WZA6
DANTYRQRLPAFTML	ODF3L2	211	Q3SX64
NPFIYSLRNRDMKGA	OR1E1	286	P30953
PSFRQNALYVRMLAE	SNX13	501	Q9Y5W8
GFREIEMSKFRYNPS	SLC4A11	611	Q8NBS3
PYQAAEQDMRVLRGA	SUMF2	241	Q8NBJ7
INLTDPMFRGIYRGV	TATDN1	11	Q6P1N9
EREGATPYNSRTVMN	SLC6A6	591	P31641
RNPQFRIFAYLMAVI	RNF183	156	Q96D59
ISIRQRFIGKPDMAY	SNAP47	311	Q5SQN1
MANRGPAYGLSREVQ	TAGLN2	1	P37802
MANRGPSYGLSREVQ	TAGLN3	1	Q9UI15
LRFANTIPFYGTMVN	SLC22A10	356	Q63ZE4
VSQALRENTYPFLAM	FAF2	221	Q96CS3
LRRVAGSMGFNVDYP	PIWIL4	506	Q7Z3Z4
VSAFGIIPRNNRLMY	PUS7	461	Q96PZ0
QRAGLVFPNMEAYAV	ST6GALNAC6	201	Q969X2
EAYAVSPGRMRQFDD	ST6GALNAC6	211	Q969X2
YPDAFMREELSQRLG	SHOX	141	O15266
FRQRLQEMGFIIYGN	SPTLC3	441	Q9NUV7
RGNSATMVRVVPYAA	SLC25A42	91	Q86VD7
RYQHMGRVLLFQEPQ	ITGAL	426	P20701
AAMYQAVGELPQANR	RACGAP1	456	Q9H0H5
MRRNKTPDYRGQHVF	STARD8	556	Q92502
MPQFSTIEYVIQRGA	SEC23B	111	Q15437
EPRKGFMYSRNTNEN	SLC39A6	246	Q13433
RPNAGFMRQLSEYEG	SSH1	431	Q8WYL5
FPQAARQERYSSLMV	ABCA8	1536	O94911
TPIFRDAGMQLQGYR	GOT2	166	P00505
PRDRNFLFVGVMTAQ	CHSY1	81	Q86X52
RAPVAQTSRMYEFVG	CHST4	281	Q8NCG5
LNMTRGAAYGADRPF	CHST7	406	Q9NS84
TYRGGMAINRFRLEN	COASY	291	Q13057
TETRTNYPNMFRIGN	CNGA3	291	Q16281
QQPEADLYRFMGRMI	ATP11B	211	Q9Y2G3
SMSQAPYCVRNVRFG	ACAA2	121	P42765
IVARYVQPMASFARD	SUPT6H	1411	Q7KZ85
SYQRMPGNAMVRGFR	SENP3	366	Q9H4L4
IYNSRPMRLAFAVVF	TMEM268	96	Q5VZI3
MRDFVSYPSAGNERL	TULP4	426	Q9NRJ4
YMRLASGNPAIVQDA	WDFY3	2441	Q8IZQ1
SPFTNAYRRNGMAFL	SUPT3H	301	O75486
PGQRNIYRDVMRATF	ZNF490	76	Q9ULM2
DNRAQSFRPLTAEMY	SLC27A5	666	Q9Y2P5
VYSMNDVRRAFLGPF	SEMA3B	341	Q13214
RFIYTGRAPNLDKMA	SPOPL	256	Q6IQ16
LNYMDRFTVAGVLPD	SPNS1	71	Q9H2V7
DTFAYFQLRMRVPEG	TNXB	986	P22105
FTVQYKDRDGRPQVM	TNXB	2766	P22105
RQMGYSSKPTFRAVE	TMPRSS4	141	Q9NRS4
RAGRLDVMSQNPYNA	WDR46	316	O15213
MAAATLRDPAQQGYV	ZNF773	1	Q6PK81
DGVRNYQARNFLRAM	THYN1	91	Q9P016
YPENGVVQMNSRDVR	UHRF1	191	Q96T88
RQLFRQFRYQVMSGP	ZNF18	41	P17022
ISMRPDFKQAYISRG	TMTC3	556	Q6ZXV5
FPSRVFMDSNGIRQF	TCTN3	146	Q6NUS6
TFGSRAYLQPMDTRQ	TRAPPC13	236	A5PLN9
DPGFVVTLSNRMNYF	USP7	806	Q93009
GVFMRVSEVKPTYRN	PURA	241	Q00577
NNPSYIDRLISVFMR	TRRAP	2281	Q9Y4A5
GNMREFINSPFRDIY	TRPV4	221	Q9HBA0
RPIVNMDYVVGARTF	TERT	631	O14746
NAEYNPKRFAAVIMR	TBPL2	226	Q6SJ96
GRRQAIRGPAYMFNE	TRPC7	21	Q9HCX4
NGDYRDTGMVLVNPF	TMEM108	546	Q6UXF1
DYLPRTMDFGLNVRG	LIMK1	551	P53667
FTRAMASVARTPQQY	ART4	136	Q93070
YDGIMERIPNTAFRG	NAT8L	96	Q8N9F0
AIVDDPRYRMFSNQG	MYBPC1	1086	Q00872
PRYRMFSNQGVCTLE	MYBPC1	1091	Q00872